News - Page 20 - Psychedelic Alpha

Read more about the article Reflecting on Psychedelics in 2023

Reflecting on Psychedelics in 2023

Post published:January 16, 2024
Post category:2023 Year in Review Analysis

Read more about the article Pα+ Psychedelic Bulletin #153: MindMed Scraps Microdosing Program; Eagerly Anticipated Ibogaine Study Publishes; Compass Collaborates with Greenbrook; Gilgamesh’s GM-1020 Readout; and more…

Pα+ Psychedelic Bulletin #153: MindMed Scraps Microdosing Program; Eagerly Anticipated Ibogaine Study Publishes; Compass Collaborates with Greenbrook; Gilgamesh’s GM-1020 Readout; and more…

Post published:January 12, 2024
Post category:Psychedelic Bulletin Pα+

Read more about the article Our Top 10 Psychedelics Articles in 2023

Our Top 10 Psychedelics Articles in 2023

Post published:January 11, 2024
Post category:2023 Year in Review Analysis

Read more about the article Natural Medicine Advisory Bulletin #7: December 2023

Natural Medicine Advisory Bulletin #7: December 2023

Post published:January 10, 2024
Post category:Colorado Natural Medicine Advisory Bulletin

Read more about the article The Obscure Advisory Panel Blocking Dozens of Psychedelic Studies in California

The Obscure Advisory Panel Blocking Dozens of Psychedelic Studies in California

Post published:January 9, 2024
Post category:Analysis News

Read more about the article The Psychedelic News Feed: Dec 11 2023 – Jan 7, 2024

The Psychedelic News Feed: Dec 11 2023 – Jan 7, 2024

Post published:January 8, 2024
Post category:Psychedelic News Feed Archive

Read more about the article Pα+ Psychedelic Patent Analysis (November 2023)

Pα+ Psychedelic Patent Analysis (November 2023)

Post published:January 5, 2024
Post category:Psychedelic Patent Analysis Pα+

Read more about the article MAPS PBC Closes $100m Series A, Rebrands to Lykos Therapeutics

MAPS PBC Closes $100m Series A, Rebrands to Lykos Therapeutics

Post published:January 5, 2024
Post category:Analysis News

Read more about the article Psychedelic Research Bulletin: December 2023

Psychedelic Research Bulletin: December 2023

Post published:January 4, 2024
Post category:Psychedelics Research Review

Read more about the article atai Life Sciences Makes $50m Investment in Beckley Psytech

atai Life Sciences Makes $50m Investment in Beckley Psytech

Post published:January 4, 2024
Post category:Analysis News

End of content

No more pages to load

Psychedelic Alpha

Psychedelic Alpha is an independent newsletter and community that strives to empower a diverse constellation of individuals and organisations with the knowledge, network and nuance to make an impact within the field of psychedelic medicine and beyond

Quick Links

Newsletter

Insights and interviews delivered to your inbox. No spam, just valuable information.